Global Cell and Gene Therapy Market Size to Exceed USD 46.70 Billion by 2035 | (CAGR) of 17.81%
Category: HealthcareGlobal Cell and Gene Therapy Market Size to Exceed USD 46.70 Billion by 2035
According to a research report published by Spherical Insights & Consulting, The Global Cell and Gene Therapy Market Size was worth Around USD 7.70 Billion 2024, Growing to USD 8.84 Billion in 2025, and is predicted to Grow to Around USD 46.70 Billion by 2035 with a compound Annual Growth Rate (CAGR) of 17.81% from 2025 to 2035.
Get more details on this report -
Browse 251 Market Data Tables And 110 Figures Spread Through 190 Pages and In-Depth TOC On The "Global Cell and Gene Therapy Market Size, Share, and COVID-19 Impact Analysis, By Therapeutic Class (Cardiovascular Disease, Cancer, Genetic Disorder, Rare Diseases, Oncology, Hematology, Ophthalmology, Infectious Disease, Neurological Disorders, and Others), By End User (Hospitals, Cancer Care Centers, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/cell-and-gene-therapy-market
The global industry dedicated to the creation, production, and marketing of novel therapeutic solutions that use cellular and genetic material to treat, prevent, or possibly cure a range of diseases is known as the cell and gene therapy market. These treatments entail altering or modifying genes or cells to improve the body's resistance to diseases, such as cancer, chronic illnesses, and genetic disorders, or to restore normal function. The industry offers a wide variety of goods, such as regenerative medicine solutions, cell-based immunotherapies, and gene editing technology. Pharmaceutical and biotechnology businesses' increasing R&D expenditures also support market growth. The market's strong growth is being driven by advancements in healthcare infrastructure, especially in emerging markets, which are making cell and gene therapies more widely accessible and applicable. The adoption rates of these medicines are also being driven by growing patient and healthcare provider knowledge of their potential advantages. However, the expansion of the cell and gene therapy market is restricted by high development costs, intricate manufacturing procedures, strict regulatory regulations, and restrictive reimbursement policies.
The infectious disease segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the therapeutic class, the cell and gene therapy market is divided into cardiovascular disease, cancer, genetic disorder, rare diseases, oncology, hematology, ophthalmology, infectious disease, neurological disorders, and others. Among these, the infectious disease segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The sector is being driven by the increasing need for genome editing methods, such as CRISPR/Cas, for infectious diseases.
The hospitals segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the end user, the cell and gene therapy market is divided into hospitals, cancer care centers, and others. Among these, the hospitals segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Hospitals are the main locations for delivering cutting-edge therapeutics including gene and cell therapies, particularly for hereditary and chronic illnesses.
North America is expected to hold the majority share of the global cell and gene therapy market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global cell and gene therapy market during the forecast period. The region's sophisticated healthcare system, significant investments in biotechnology R&D, and a supportive regulatory environment that facilitates the quick approval and commercialization of novel treatments are what propel North America. Furthermore, North America's strong growth and market leadership are largely due to the high prevalence of hereditary and chronic diseases as well as the existence of major pharmaceutical and biotechnology industries.
Asia Pacific is anticipated to grow at the fastest pace in the global cell and gene therapy market during the forecast period. The rising incidence of hereditary and chronic illnesses, rising healthcare spending, and developing healthcare infrastructure are the main drivers of the Asia Pacific region. The region's rapid uptake of cell and gene therapies is also being aided by encouraging government measures and growing patient and healthcare provider awareness of sophisticated therapies.
Major vendors in the global cell and gene therapy market are Pfizer Inc., Amgen Inc., Biogen Inc., Novartis AG, CORESTEM Inc., Helixmith Co. Ltd., Kolon TissueGene Inc., JCR Pharmaceuticals Co. Ltd., Alnylam Pharmaceuticals Inc., Dendreon Pharmaceuticals LLC, and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In April 2025, Researchers introduced state-of-the-art advancements in base and prime editors, safer AAV delivery systems, and innovative CAR-T/CAR-NK therapies that target autoimmune, neurological, and sensory-organ illnesses at the "Gene and Cell Therapies: The Path to Clinic" conference in Wenzhou.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the cell and gene therapy market based on the below-mentioned segments:
Global Cell and Gene Therapy Market, By Therapeutic Class
- Cardiovascular Disease
- Cancer
- Genetic Disorder
- Rare Diseases
- Oncology
- Hematology
- Ophthalmology
- Infectious Disease
- Neurological Disorders
- Others
Global Cell and Gene Therapy Market, By End User
- Hospitals
- Cancer Care Centers
- Others
Global Cell and Gene Therapy Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?